Clinical Trials Sponsored by Novartis Germany GmbH

Total 292 results

Charite University, Berlin, Germany
Novartis Germany GmbH

Completed

Evaluation of Sloan-Charts for Assessment of Disease Progress in Multiple Sclerosis

Multiple Sclerosis

Germany
AIO-Studien-gGmbH
Merck Serono GmbH, Germany

Terminated

Neoadjuvant Bintrafusp Alfa in Patients With Resectable Biliary Tract Cancer (NEOBIL)

Cholangiocarcinoma | Biliary Tract Cancer

Germany
University of Kiel
Deutsche Forschungsgemeinschaft, Bonn, Germany; Novartis Pharma GmbH, Nürnberg...

Completed

Pimecrolimus and Epidermal Barrier Function

Atopic Dermatitis

Germany
Charite University, Berlin, Germany
German Research Foundation; adexter GmbH

Completed

Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)

Septicemia

Germany
AbbVie
IST GmbH, Germany

Completed

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary (VERITAS)

Chronic Hepatitis C
AbbVie
IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Belgium

Chronic Hepatitis C, Genotype 1 or 4
AbbVie
IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

Chronic Hepatitis C
AbbVie
IST GmbH, Germany

Completed

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Chronic Hepatitis C
Universitätsklinikum Hamburg-Eppendorf
Federal Joint Committee; aQua-Institut GmbH, Germany; Leibniz-Institut für Resilienzforschung... and other collaborators

Active, not recruiting

Family Health Partners in Regional Network Structures (NEST)

Disabled or Chronically Ill Children in Need of Care

Germany
AbbVie
Hannover Medical School; IST GmbH, Germany; Improvement by Movement GmbH, Germany

Terminated

A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment (STRIKE)

Axial Spondyloarthritis
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany

Completed

To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta Liquid Pen

Infertility | Ovulation Induction
Merck KGaA, Darmstadt, Germany
Merck Serono GmbH, Germany

Completed

Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone) (LODOTRA)

Arthritis, Rheumatoid

Germany
Shire
Nycomed Germany GmbH

Completed

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

Short Bowel Syndrome

Spain, United States, Canada, France, Denmark, Poland, Germany, Italy, United Kingdom
Sanofi
Profil GmbH, Neuss, Germany

Completed

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (RESTORE)

Diabetes Mellitus, Type 2

Germany
AIO-Studien-gGmbH
Universitätsklinikum Hamburg-Eppendorf; Merck Serono GmbH, Germany; Pierre Fabre...

Recruiting

Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer (NeoBRAF)

Colorectal Cancer | Colon Cancer | BRAF V600 Mutation | BRAF V600E | Localized Cancer

Germany
GWT-TUD GmbH
Novartis

Completed

Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers

Diabetic Macular Edema

Germany
GWT-TUD GmbH
Novartis

Unknown

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema (ReCaLL)

Diabetic Macular Edema

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Influence of an Oral Nutritional Supplement Rich in Omega-3 Fatty Acids on Functional State and Quality of Life in Malnourished Patients With Gastroenterological Tumors

Colorectal Neoplasms | Hepatocellular Carcinoma | Cholangiocarcinoma

Germany
Charite University, Berlin, Germany
Pfrimmer Nutricia GmbH, Erlangen , Germany

Completed

Medical and Health Economic Benefit of Oral Nutritional Supplements (ONS) in Ambulant Patients (ECONONS)

Malnutrition

Germany
North Eastern German Society of Gynaecological...
Novartis Pharmaceuticals; medac GmbH

Active, not recruiting

Pazopanib vs. Pazopanib Plus Gemcitabine (PazoDoble)

Leiomyosarcoma or Carcinosarcoma

Germany
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Neuroendocrine Neoplasms

Japan
Charite University, Berlin, Germany
Novartis

Completed

Pharmacokinetics of Everolimus and Enteric-Coated Mycophenolatesodium Before and After Withdrawal of Cyclosporine in Renal Transplant Patients

Renal Transplantation

Germany
Novartis Pharmaceuticals
Eckert & Ziegler Radiopharma GmbH

Recruiting

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Prostate Cancer

Japan
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
German Heart Institute
Novartis

Unknown

Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

Coronary Artery Disease | Coronary Restenosis

Germany
Charite University, Berlin, Germany
ribosepharm GmbH

Unknown

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Recurrent Small Cell Lung Cancer

Germany
Charite University, Berlin, Germany
HeVaTech GmbH

Completed

Pulsatile Cupping in Low Back Pain (Cupping-LBP)

Chronic Low Back Pain

Germany
AbbVie
Cato Research; IST GmbH, Germany

Completed

Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Canada (AMBER)

Chronic Hepatitis C
German Breast Group
Novartis

Completed

Dose EScalation Induction of EvERolimus (Desiree)

Breast Cancer | Hormone Receptor Positive Tumor

Germany
German Breast Group
Novartis

Terminated

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane (Evelyn)

Metastatic Breast Cancer

Germany
German Breast Group
Novartis

Unknown

Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases (RADAR)

Breast Cancer

Germany
DiaNe HCM GmbH
Roche Pharma Deutschland GmbH, Grenzach-Wyhlen, Germany; Institute for Medical...

Completed

Evaluation Study for the Programme DiaNe for People With Diabetic Nephropathy (DiaNe)

Diabetic Nephropathy

Germany
GWT-TUD GmbH
Novartis Pharmaceuticals

Completed

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (Secu_in_AD)

Dermatitis, Atopic | Eczema, Atopic | Neurodermatitis, Atopic

Germany
Follicum AB
proDERM GmbH; Hair and Skin Institute, Charité, Berlin, Germany; Centroderm GmbH...

Completed

A Phase 2a Trial of FOL-005 Topical Formulations to Investigate Hair Growth Potential and Safety in Healthy Male Volunteers

Androgenetic Alopecia

Germany
AIO-Studien-gGmbH
Novartis Pharmaceuticals; Assign Data Management and Biostatistics GmbH

Completed

Safety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II Study (EVINEC)

Neuroendocrine Carcinoma, Grade 3 | Poorly Differentiated Malignant Neuroendocrine Carcinoma | Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3 | Neuroendocrine Carcinoma, Grade 2 [Moderately Differentiated Neuroendocrine Carcinoma]... and other conditions

Germany
Charite University, Berlin, Germany
Novartis Pharmaceuticals

Completed

Cold Urticaria Treatment With Xolair (CUTEX)

Cold Contact Urticaria

Germany
Charite University, Berlin, Germany
Novartis Pharmaceuticals

Completed

Urticaria Facticia Treatment With Omalizumab (UFO) (UFO)

Symptomatic Dermographism

Germany
Charite University, Berlin, Germany
Novartis Pharmaceuticals

Completed

Ilaris® Effects in Schnitzler Syndrome (ILESCH) (ILESCH)

Schnitzler Syndrome

Germany
Charite University, Berlin, Germany
Novartis Pharmaceuticals

Completed

Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses (ILUVIT)

Vasculitis | Urticaria

Germany
University of Ulm
Medac GmbH (Hamburg, Germany); Roche (Grenzach-Wyhlen, Germany)

Completed

Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon Cancer (FOGT1)

Rectal Cancer

Germany
Charite University, Berlin, Germany
Sanofi; Proinnovera GmbH

Completed

Cholinergic Urticaria - Efficacy of Dupilumab (CHED)

Cholinergic Urticaria

Germany
University of Southern Denmark
SignaTope GmbH, Germany

Completed

Flucloxacillin as an Inducer of CYP-enzymes

Healthy Volunteers | Drug Drug Interaction

Denmark
Charite University, Berlin, Germany
Essex Pharma GmbH

Completed

Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU) (AUD2OCU)

Chronic Urticaria

Germany
Provitro GmbH
Charite University, Berlin, Germany; AstraZeneca

Completed

Pathomolecular Analysis of Rare EGFR Mutations in Advanced NSCLC

Mutations in Exons 18 to 21

Germany
Charite University, Berlin, Germany
Seibersdorf Labor GmbH

Suspended

Effects of WiFi Exposure on Sleep in Women

Sleep

Germany
Charite University, Berlin, Germany
Shire International GmbH

Active, not recruiting

Lanadelumab in FXII-associated Cold Autoinflammatory Syndrome (FACAS) (LANA-FXII)

Hereditary Autoinflammatory Disease

Germany
Medtronic Bakken Research Center
Medtronic GmbH Germany

Completed

Protecta Smart Analysis Register (ProSA)

Patients With an Indication for an ICD Implantation According to the Guidelines
Charite University, Berlin, Germany
Sysmex Europe GmbH

Completed

Hematological Infection Score Compared to the Hospital Standard for Diagnosis of SIRS or Sepsis on ICU

Sepsis | SIRS

Germany
Charite University, Berlin, Germany
Johnson & Johnson GmbH

Completed

Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life

Postnatal Skin Physiology
Charite University, Berlin, Germany
Reactive Robotics GmbH

Completed

Robotic Assisted Early Mobilization in Ventilated ICU Patients (ROBEM-I)

Critical Illness | Rehabilitation | Early Ambulation | Critical Illness Polyneuromyopathy

Germany

Clinical Trials Sponsored by Novartis Germany GmbH

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations